Hyperthyroidism.
Chaker L, Cooper DS, Walsh JP, Peeters RP.
Lancet. 2024 Feb 24;403(10428):768-780. doi: 10.1016/S0140-6736(23)02016-0. Epub 2024 Jan 23.
AMIODARONE AND THYROID DYSFUNCTION.
Medić F, Bakula M, Alfirević M, Bakula M, Mucić K, Marić N.
Acta Clin Croat. 2022 Aug;61(2):327-341. doi: 10.20471/acc.2022.61.02.20.
Amiodarone-induced thyrotoxicosis.
Anfinsen OG, Lima K.
Tidsskr Nor Laegeforen. 2021 Nov 8;141(16). doi: 10.4045/tidsskr.21.0047. Print 2021 Nov 9.
Antithyroid drugs.
Cooper DS.
N Engl J Med. 2005 Mar 3;352(9):905-17. doi: 10.1056/NEJMra042972.
Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature.
Maqdasy S, Benichou T, Dallel S, Roche B, Desbiez F, Montanier N, Batisse-Lignier M, Tauveron I.
Ann Endocrinol (Paris). 2019 Feb;80(1):54-60. doi: 10.1016/j.ando.2018.05.001. Epub 2018 Sep 17.
Thyrotoxicosis.
Franklyn JA, Boelaert K.
Lancet. 2012 Mar 24;379(9821):1155-66. doi: 10.1016/S0140-6736(11)60782-4. Epub 2012 Mar 5.
Amiodarone and the thyroid.
Jabrocka-Hybel A, Bednarczuk T, Bartalena L, Pach D, Ruchała M, Kamiński G, Kostecka-Matyja M, Hubalewska-Dydejczyk A.
Endokrynol Pol. 2015;66(2):176-86. doi: 10.5603/EP.2015.0025.
Drug-induced thyrotoxicosis: the surgical option.
Lorberboym M, Schachter P.
Isr Med Assoc J. 2007 Feb;9(2):79-82.
Amiodarone and thyroid.
Eskes SA, Wiersinga WM.
Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):735-51. doi: 10.1016/j.beem.2009.07.001.
[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development].
Ermolaeva AS, Fadeev VV.
Probl Endokrinol (Mosk). 2023 Oct 23;70(3):9-22. doi: 10.14341/probl13348.
